Switch to: References

Add citations

You must login to add citations.
  1. First-in-Human Trial Participants: Not a Vulnerable Population, but Vulnerable Nonetheless.Rebecca Dresser - 2009 - Journal of Law, Medicine and Ethics 37 (1):38-50.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   16 citations  
  • Model Systems in Stem Cell Biology.Jason Scott Robert - 2004 - Bioessays 26 (9):1005-1012.
  • Human Embryonic Stem Cell Research, Justice, and the Problem of Unequal Biological Access.Mark S. Moller - 2008 - Philosophy, Ethics, and Humanities in Medicine 3:22.
    In 2003, Ruth Faden and eighteen other colleagues argued that a.
    Direct download (12 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • First-in-Human Trial Participants: Not a Vulnerable Population, but Vulnerable Nonetheless.Rebecca Dresser - 2009 - Journal of Law, Medicine and Ethics 37 (1):38-50.
    The 21st-century translational science campaign could lead to an increase in first-in-human trials. As tests of investigational interventions move from the laboratory to human research, scientists, officials, and review committees should address ongoing concerns about the ethics of FIH trials. In this article, I describe three ethical considerations relevant to all FIH trials: the requirement for adequate preclinical research; study design safeguards; and choice of subject population. I also examine specific ethical considerations relevant to the three subject populations involved in (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   15 citations